• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人胶质瘤中STK15的过表达与扩增

Overexpression and amplification of STK15 in human gliomas.

作者信息

Klein Alexandra, Reichardt Wilfried, Jung Volker, Zang Klaus D, Meese Eckart, Urbschat Steffi

机构信息

Institute of Human Genetics, Saarland University, Building 60, D-66421 Homburg/Saar, Germany.

出版信息

Int J Oncol. 2004 Dec;25(6):1789-94.

PMID:15547718
Abstract

The serine/threonine kinase 15 (STK15) at chromosome 20q13.2 is frequently shown to be amplified and overexpressed in several human cancers. STK15 has been reported to act as a cell cycle regulator and its overexpression induces centrosome amplification and aneuploidy. Recently we showed that STK15 even plays a role in human malignant brain tumours and we described an amplification of the gene in 31% of the investigated gliomas. In this study we scrutinized the correlation of increased STK15 on DNA and mRNA levels in gliomas of different histological grades. Southern blotting confirmed the amplification frequency of the STK15 gene, which had been previously detected by comparative PCR. In total, DNA gains were found in 26% of the investigated gliomas. Interestingly, we detected overexpression of STK15 mRNA in 60% of the analyzed brain tumours. The elevated expression does not strongly correlate with gains on DNA level, but all cases with an amplification of the STK15 gene display overexpression. Gains of the STK15 gene seem to occur irrespectively of the histological grades of the tumours, so that STK15 probably is not a progression associated factor. Amplification and overexpression of the kinase rather represent a primary alteration in human gliomas, which could play an important role as an early event in all glioma subtypes.

摘要

位于20号染色体q13.2区域的丝氨酸/苏氨酸激酶15(STK15)在多种人类癌症中常表现出扩增和过表达。据报道,STK15作为一种细胞周期调节因子,其过表达会导致中心体扩增和非整倍体。最近我们发现STK15在人类恶性脑肿瘤中也发挥作用,并且在31%的被研究胶质瘤中发现了该基因的扩增。在本研究中,我们仔细研究了不同组织学分级的胶质瘤中STK15在DNA和mRNA水平增加之间的相关性。Southern印迹法证实了STK15基因的扩增频率,这一频率先前已通过比较PCR检测到。总共在26%的被研究胶质瘤中发现了DNA增加。有趣的是,我们在60%的分析脑肿瘤中检测到STK15 mRNA的过表达。表达升高与DNA水平的增加并没有很强的相关性,但所有STK15基因扩增的病例均表现出过表达。STK15基因的增加似乎与肿瘤的组织学分级无关,因此STK15可能不是一个与肿瘤进展相关的因素。该激酶的扩增和过表达更可能代表人类胶质瘤中的一种原发性改变,这可能作为所有胶质瘤亚型的早期事件发挥重要作用。

相似文献

1
Overexpression and amplification of STK15 in human gliomas.人胶质瘤中STK15的过表达与扩增
Int J Oncol. 2004 Dec;25(6):1789-94.
2
The putative serine/threonine kinase gene STK15 on chromosome 20q13.2 is amplified in human gliomas.位于20号染色体q13.2区域的假定丝氨酸/苏氨酸激酶基因STK15在人类胶质瘤中发生扩增。
Oncol Rep. 2003 Sep-Oct;10(5):1275-9.
3
Detailed chromosomal characterization of the breast cancer cell line MCF7 with special focus on the expression of the serine-threonine kinase 15.对乳腺癌细胞系MCF7进行详细的染色体特征分析,特别关注丝氨酸-苏氨酸激酶15的表达。
Oncol Rep. 2005 Jul;14(1):23-31.
4
Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation.肿瘤扩增激酶STK15/BTAK可诱导中心体扩增、非整倍体及细胞转化。
Nat Genet. 1998 Oct;20(2):189-93. doi: 10.1038/2496.
5
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human pancreatic cancer.致癌性丝氨酸/苏氨酸激酶15/膀胱癌激活激酶/极光激酶A在人类胰腺癌中的过表达
Clin Cancer Res. 2003 Mar;9(3):991-7.
6
Cyclin-dependent kinase 6 (CDK6) amplification in human gliomas identified using two-dimensional separation of genomic DNA.利用基因组DNA二维分离技术鉴定人胶质瘤中细胞周期蛋白依赖性激酶6(CDK6)的扩增
Cancer Res. 1997 Apr 1;57(7):1250-4.
7
Differential gene expression profile in endometrioid and nonendometrioid endometrial carcinoma: STK15 is frequently overexpressed and amplified in nonendometrioid carcinomas.子宫内膜样癌和非子宫内膜样癌中的差异基因表达谱:STK15在非子宫内膜样癌中经常过度表达和扩增。
Cancer Res. 2003 Sep 15;63(18):5697-702.
8
Amplification and overexpression of Aurora-A in esophageal squamous cell carcinoma.极光激酶A(Aurora-A)在食管鳞状细胞癌中的扩增与过表达。
Oncol Rep. 2007 May;17(5):1083-8.
9
STK15 gene overexpression, centrosomal amplification, and chromosomal instability in the absence of STK15 mutations in laryngeal carcinoma.喉癌中STK15基因过表达、中心体扩增以及在无STK15突变情况下的染色体不稳定
Cancer Invest. 2005;23(8):660-4. doi: 10.1080/07357900500359836.
10
Centrosome-, chromosomal-passenger- and cell-cycle-associated mRNAs are differentially regulated in the development of sporadic colorectal cancer.中心体、染色体乘客蛋白及细胞周期相关的信使核糖核酸在散发性结直肠癌的发展过程中受到不同程度的调控。
J Pathol. 2006 Mar;208(4):462-72. doi: 10.1002/path.1914.

引用本文的文献

1
Aurora kinase A expression in pleomorphic adenoma, adenoid cystic carcinoma, and mucoepidermoid carcinoma of salivary glands: an immunohistochemical study.唾液腺多形性腺瘤、腺样囊性癌和黏液表皮样癌中极光激酶A的表达:一项免疫组织化学研究。
BMC Oral Health. 2025 Jan 17;25(1):89. doi: 10.1186/s12903-024-05276-5.
2
A multivariate retrospective analysis of high-grade gliomas: Survival and prognostic factors.多变量回顾性分析高级别胶质瘤:生存和预后因素。
Cancer Med. 2024 Aug;13(15):e7456. doi: 10.1002/cam4.7456.
3
Pharmacological inhibition of the ubiquitin-specific protease 8 effectively suppresses glioblastoma cell growth.
泛素特异性蛋白酶8的药理学抑制有效抑制胶质母细胞瘤细胞生长。
Open Life Sci. 2023 Feb 9;18(1):20220562. doi: 10.1515/biol-2022-0562. eCollection 2023.
4
G2/M inhibitors as pharmacotherapeutic opportunities for glioblastoma: the old, the new, and the future.G2/M期抑制剂作为胶质母细胞瘤的药物治疗契机:过去、现在与未来
Cancer Biol Med. 2018 Nov;15(4):354-374. doi: 10.20892/j.issn.2095-3941.2018.0030.
5
Potential Strategies Overcoming the Temozolomide Resistance for Glioblastoma.克服胶质母细胞瘤替莫唑胺耐药性的潜在策略
Neurol Med Chir (Tokyo). 2018 Oct 15;58(10):405-421. doi: 10.2176/nmc.ra.2018-0141. Epub 2018 Sep 21.
6
Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma.在贝伐单抗耐药的、源自患者的胶质母细胞瘤原位模型中,阿利塞替布表现出显著的抗肿瘤活性。
J Neurooncol. 2017 Jan;131(1):41-48. doi: 10.1007/s11060-016-2285-8. Epub 2016 Nov 5.
7
The Unexpected Roles of Aurora A Kinase in Gliobastoma Recurrences.Aurora A 激酶在胶质母细胞瘤复发中的意外作用。
Target Oncol. 2017 Feb;12(1):11-18. doi: 10.1007/s11523-016-0457-2.
8
Aurora-A is a novel predictor of poor prognosis in patients with resected lung adenocarcinoma.极光激酶 A 是预测肺腺癌患者术后预后不良的一个新标志物。
Chin J Cancer Res. 2014 Apr;26(2):166-73. doi: 10.3978/j.issn.1000-9604.2014.04.08.
9
Aurora-A signaling is activated in advanced stage of squamous cell carcinoma of head and neck cancer and requires osteopontin to stimulate invasive behavior.极光激酶A信号通路在头颈癌鳞状细胞癌的晚期被激活,并且需要骨桥蛋白来刺激侵袭行为。
Oncotarget. 2014 Apr 30;5(8):2243-62. doi: 10.18632/oncotarget.1896.
10
Aurora-A is an efficient marker for predicting poor prognosis in human nasopharyngeal carcinoma with aggressive local invasion: 208 cases with a 10-year follow-up from a single institution.极光激酶A是预测具有侵袭性局部侵犯的人类鼻咽癌预后不良的有效标志物:来自单一机构的208例患者的10年随访研究
Oncol Lett. 2012 Jun;3(6):1237-1244. doi: 10.3892/ol.2012.660. Epub 2012 Mar 27.